Cargando…
Multidrug Resistance and Cancer Stem Cells in Neuroblastoma and Hepatoblastoma
Chemotherapy is one of the major modalities in treating cancers. However, its effectiveness is limited by the acquisition of multidrug resistance (MDR). Several mechanisms could explain the up-regulation of MDR genes/proteins in cancer after chemotherapy. It is known that cancer stem cells (CSCs) pl...
Autores principales: | Alisi, Anna, Cho, William C., Locatelli, Franco, Fruci, Doriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876137/ https://www.ncbi.nlm.nih.gov/pubmed/24351843 http://dx.doi.org/10.3390/ijms141224706 |
Ejemplares similares
-
Epigenetic Deregulation of MicroRNAs in Rhabdomyosarcoma and Neuroblastoma and Translational Perspectives
por: Romania, Paolo, et al.
Publicado: (2012) -
Role of Endoplasmic Reticulum Aminopeptidases in Health and Disease: from Infection to Cancer
por: Cifaldi, Loredana, et al.
Publicado: (2012) -
Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticity
por: D’Amico, Silvia, et al.
Publicado: (2023) -
Dendritic Cells: Behind the Scenes of T-Cell Infiltration into the Tumor Microenvironment
por: Lucarini, Valeria, et al.
Publicado: (2021) -
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma
por: Brandetti, Elisa, et al.
Publicado: (2017)